FDA Recalls Fentanyl Injections Due to Sterility Assurance Concerns
Central Admixture Pharmacy Services is recalling 1,197 syringes of fentanyl injectable solution due to lack of validation for sterilization cycles. The product was distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall for sterility assurance failure in a compounded injectable. No reported illnesses or injuries. Per rubric, Class II recalls without reported harm and with theoretical contamination hazard score at most 3 (High).
Plain-English summary
Central Admixture Pharmacy Services Inc is recalling approximately 1,197 syringes of fentanyl in dextrose 5% solution (10 mcg/mL, 30 mL syringes). This is a prescription injectable medication distributed nationwide in the USA.
The recall was initiated because the manufacturer lacks adequate validation data for the sanitization cycles used in the compounding process, raising concerns about whether the product meets sterility standards.
The affected product includes the following lot numbers and expiration dates: 17-271144 (exp. 7/25/2023), 17-271354 (exp. 7/27/2023), 17-271681 (exp. 8/2/2023), 17-271990 (exp. 8/7/2023), and 17-272457 (exp. 8/16/2023). Healthcare providers and dispensing facilities should discontinue use of affected lots. Patients who have received this product should contact their healthcare provider for guidance.
The recalled product
- Product
- fentaNYL in dextrose 5%, 300 mcg/30 mL, (10 mcg/mL), 30 mL syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C San Diego, CA 92126, NDC: 71286-2001-2
- Manufacturer
- Central Admixture Pharmacy Services Inc
- Category
- Drug — Injectable / Compounded
- Hazard
- Affected units
- 1,197
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- Lot: 17-271144
- Exp. 7/25/2023
- 17-271354
- Exp. 7/27/2023
- 17-271681
- Exp. 8/2/2023
- 17-271990
- Exp. 8/7/2023
- 17-272457
- Exp. 8/16/2023.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 39 recalled by Central Admixture Pharmacy Services Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 39 products in this recall →Related recalls
Same manufacturer · Central Admixture Pharmacy Services Inc
See all →- ModeratePediatric TPN Bags Recalled for Incorrect Formulation
FDA (Drugs) · 2026-08-12
- SeverePediatric Total Parenteral Nutrition Bag Recalled for Incorrect Formulation
FDA (Drugs) · 2026-07-01
- SevereInjectable Phenylephrine Solution Recalled Due to Particulate Matter Contamination
FDA (Drugs) · 2025-03-19
- HighInjectable Lidocaine Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-10-11
- HighMidazolam Injectable Solution Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2023-10-11
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29